semaglutide massachusetts for weight loss | Blog semaglutide massachusetts does masshealth cover

After spending $120 million on weight-loss drugs in fiscal 2025, the Group Insurance Commission, which provides health insurance to all state employees and retirees, decided it would offer the drugs a new way in 2026

But as scientists and drug developers isolate the mechanisms behind their anti-cancer, anti-dementia, and anti-inflammatory effects, we might get specially tailored drugs for cancer, dementia, and inflammation

GLP-1 Agonists (Semaglutide, Tirzepatide) FDA Status: Fully approved for type 2 diabetes and obesity Brand Names: Ozempic, Wegovy (semaglutide)

Human Research Findings The majority of current data on BPC-157 originates from animal studies, demonstrating consistent advantages in tissue healing, angiogenesis, and inflammatory regulation [1][4]